Synthetic biology can prolong anti-malaria drug effectivenessMarch 7th, 2009 - 6:07 pm ICT by IANS
Washington, March 7 (IANS) Synthetic biology can provide a simpler and cheaper way of making artemisinin, the most powerful anti-malaria drug and also help prolong its effectiveness.
Fermenting artemisinin via engineered microbes like yeast can be done at a much lower cost than extracting the drug from Artemsisia annua, the sweet wormwood tree.
Restricting access to this technology to responsible manufacturers who will bundle artemisinin as part of an anti-malarial drug “cocktail” rather than selling it as a monotherapy should delay or even prevent malarial parasites from developing resistance.
Recently, there have been reports of malaria parasites in West Africa showing some signs of resistance to artemisinin.
“The problem has been that some manufacturers have sold artemisinin as a monotherapy rather than as a co-therapy as is recommended by the World Health Organisation,” said Jay Keasling, CEO of the department of energy’s Joint BioEnergy Institute (JBEI).
Keasling, a chemical engineer at Berkeley Lab and University of California-Berkeley (UC-B), led the development of this microbial-based method of producing artemisinin.
“Any drug that is used as a monotherapy raises the possibility of microbes developing resistance to it. Right now artemisinin is grown by farmers all over the world and sold to anybody. Through the synthetic biology technique, access to the cheapest artemisinin can be restricted to manufacturers who agree to sell it as part of a co-therapy drug.”
Keasling made his remarks at a press briefing at the annual meeting of the American Association for the Advancement of Science (AAAS), said an Eurekalert release.
“Synthetic biology is somewhat like building a computer from the off-the-shelf parts,” Keasling said. “You have a knowledge base, off-the-shelf components, a system for assembling these parts and an idea as to what you want to do.”
-Indo-Asian News Service
- Natural compounds could pave way for novel anti-malaria drugs - Mar 15, 2011
- Resistance to malaria drug rings alarm bells - Apr 08, 2012
- New gene study paves way for more anti-malaria treatments - Oct 11, 2010
- Drug-resistant Malaria spreads along Thai-Myanmar border - Apr 06, 2012
- Malaria parasite developing drug resistance in Cambodia - Jul 30, 2009
- Now, a cheap and organic drug treatment for malaria - Aug 17, 2010
- Ineffective monotherapies dominating high-burden malarious countries - Nov 02, 2009
- Scientists develop microbe that produces fuels directly from biomass - Jan 28, 2010
- New strategies reducing malaria deaths in Odisha (April 25 is World Malaria Day) - Apr 25, 2012
- New class of compounds to combat malaria - Nov 20, 2011
- Synthetic biology may provide 500 million malaria patients drugs at a 10th of current cost - Jun 04, 2008
- Boosting availability of potent anti-malaria drug - Jan 18, 2012
- Novel anti-malarial drug candidate discovered - Sep 03, 2010
- Malaria treatment developed using synthetic biology, fermentation - Feb 28, 2009
- Chinese scientist wins US award for malaria drug - Sep 15, 2011
Tags: american association for the advancement of science, american association for the advancement of science aaa, asian news, berkeley lab, bioenergy, building a computer, chemical engineer, department of energy, drug cocktail, drug effectiveness, jay keasling, malaria drug, malaria parasites, malarial parasites, microbes, monotherapy, shelf components, university of california berkeley, west africa, world health organisation